Hey (@Investor_No_1): Valid Points.
All have a big 140Cr. population opportunity. Like Abbott, I have not followed others and am not in a position to make an opinion on the fly. Equity valuation demands a long term thinking to form a view about the prevailing prices. However, one must take action in the short term as per the change in circumstances since competition was there, is there and will be there.
I read Mudit’s view on another thread and was providing him with another perspective. Needless to say, all opinions are proven wrong sooner or later in the equity market.
Both Nestle India and Abbott are good businesses. However, mispriced valuation might make either or both of them great buys. One shall do the home work and be ready to load as and when the opportunity knocks.
Subscribe To Our Free Newsletter |